Discounted cost per QALY of a one-off treatment cost with a level yearly QALY gain

Divides an incremental cost paid entirely at the start (year 0), which discounting leaves unchanged, by the discounted total of a level yearly QALY gain counted at the end of each year, as in HE-FM-DISC-001. Only the QALYs shrink, so the ratio rises with the rate. This is the calculation behind the article's worked example.

Signature

ICER = C_0 * r / (q * (1 - (1 + r)^(-T)))
Inputs
InputsDefinitionUnit
C_0Incremental cost paid in year 0, compared with usual carepounds
rAnnual rate applied to costs and QALYs alike, written as a decimala proportion per year, above zero
qIncremental QALYs gained in each year after treatment, the same every yearQALYs per year
TNumber of years over which the gain lasts, counted at the end of each yearyears
Output
ICERIncremental cost per QALY gained after discounting the QALY streampounds per QALY

Function

Discounting of yearly cost and QALY streams to present-value totals

Maps a stream of yearly costs or QALYs, an annual discount rate, a time horizon and a timing convention to one discounted total, by multiplying each year's amount by its discount factor and adding the results. Totals for costs and for QALYs are formed separately and then compared across options, for example as an incremental cost per QALY. The present value of a single amount, the general sum over a stream and separate rates for costs and health are on the Discount Rate page (HE-FM-DR-001 to HE-FM-DR-003), and unequal rates on the Differential Discounting page (HE-FN-DDIS-001). This package adds the totals of a level yearly stream counted at the end of each year, at the start of each year and continuously, and the discounted cost per QALY of a one-off treatment with a lasting gain, as in the article's worked example.

Try this function

Implementations

  • Excel

    Discounted cost per QALY of a one-off treatment in one cell

    With the cost in OneOffCost, the yearly gain in YearlyQALYs, the rate in DiscRate and the years in Years, the cell divides the undiscounted cost by the discounted QALYs from PV.

    =OneOffCost/PV(DiscRate,Years,-YearlyQALYs)

Assumptions

  • Whole incremental cost of the one-off treatment in year 0

    All extra cost falls at the start, so its factor is 1. Later costs, such as monitoring, would need their own discounted total in the numerator.

  • Same rate for the cost and the QALYs of a one-off treatment

    Costs and QALYs share one rate, 3.5% a year in the NICE reference case. A 1.5% rate is a non-reference-case analysis that the committee may consider only when all the criteria in section 4.5.3 of PMG36 are met.

Worked examples

  • Article's one-off treatment discounted at 3.5 per cent

    GBP 300,000 at the start and 0.8 QALYs a year for 30 years give about GBP 20,389 per QALY at 3.5%, GBP 20,400 to the nearest GBP 100 in the article, against GBP 12,500 undiscounted.

    C_0 = 300000; q = 0.8; r = 0.035; T = 30; ICER = 20389.25
  • Article's one-off treatment discounted at 1.5 per cent

    At 1.5% the same treatment costs about GBP 15,615 per QALY, GBP 15,600 to the nearest GBP 100 in the article.

    C_0 = 300000; q = 0.8; r = 0.015; T = 30; ICER = 15614.70

Common errors

  • Reading the 1.5 per cent ratio as the reference-case result

    Lowering the rate from 3.5% to 1.5% cuts the article's ratio from about GBP 20,389 to GBP 15,615. The 1.5% result is a non-reference-case analysis, and NICE also asks for a highly plausible case that the benefit is maintained.

  • Expecting discounting to leave a one-off treatment ratio unchanged

    A common rate leaves the ratio unchanged only when costs and QALYs fall in the same years in the same proportions, as for a lifelong drug. With the whole cost in year 0 the ratio rises by about 63% at 3.5% over 30 years.

Sources

  • NICE discount rates for the reference case and the 1.5 per cent exception

    National Institute for Health and Care Excellence. NICE technology appraisal and highly specialised technologies guidance, the manual (PMG36). Chapter 4, economic evaluation. Published 31 January 2022, last updated 13 October 2026. Sections 4.5.1 (costs and health effects discounted at the same rate of 3.5% a year), 4.5.3 (1.5% a year for both when all the criteria are met) and 4.5.4 (a highly plausible case for the maintenance of benefits).

    View source →

  • Discounting health effects at the same rate as costs

    Attema AE, Brouwer WBF, Claxton K. Discounting in economic evaluations. PharmacoEconomics. 2018;36(7) 745-758. Section on discounting health, where healthcare resources are ultimately transformed into health, so that if they are discounted health effects should be discounted at the same rate.

    View source →

Canonical Identity

Discounted cost per QALY of a one-off treatment cost with a level yearly QALY gain | HealthEconomics.wiki